Skip to content
KFF Health News KFF Health News KFF Health News KFF Health News
Donate
  • Donate
  • Connect With Us:
  • Contact
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS
  • Trump 2.0
    • Agency Watch
    • Medicaid Watch
    • State Watch
    • Rural Health Payout
  • Public Health
  • Race & Health
  • Audio
    • KFF Health News Minute
    • What the Health?
    • Health Care Helpline
    • An Arm and a Leg
    • Silence in Sikeston
    • Epidemic
  • Investigations
    • Bill Of The Month
    • Deadly Denials
    • The Body Shops
    • Broken Rehab
    • Guns, Race, and Profit
    • Dead Zone
    • Payback: Tracking Opioid Cash
    • Overpayment Outrage
    • Diagnosis: Debt
    • ALL INVESTIGATIONS
  • More Topics
    • Abortion
    • Aging
    • Climate
    • COVID-19
    • Health Care Costs
    • Insurance
    • Medicaid
    • Medicare
    • Mental Health
    • Pharma
    • Rural Health
    • Uninsured

Search Results

Filter Results

Reset filters
Date
Custom Date Range
Topic
Content Type

Showing 61-69 of 69 results for "Sydney Lupkin"

Sort by

Grab Bag Of Goodies In 21st Century Cures Act

By Sydney Lupkin and Steven Findlay December 7, 2016 KFF Health News Original

A breakdown of winners — and a few losers — in the sprawling Cures Act approved by the House.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

When Drug Reviewers Leave The FDA, They Often Work For Pharma

By Sydney Lupkin September 27, 2016 KFF Health News Original

Researchers examine the Food and Drug Administration’s “revolving door” regarding employees who worked on cancer and hematology drugs.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

EpiPen Controversy Fuels Concerns Over Generic Drug Approval Backlog

By Sydney Lupkin September 6, 2016 KFF Health News Original

Four years after a huge push to speed generics to market, the FDA has more than 4,000 generics waiting for approval.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

CMS Identifies Hospitals Paid Nearly $1.5B In 2015 Medicare Billing Settlement

By Phil Galewitz August 23, 2016 KFF Health News Original

A year after settling billing disputes with 2,022 hospitals for 68 cents on the dollar, the government has revealed who got paid and how much.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Government-Protected ‘Monopolies’ Drive Drug Prices Higher, Study Says

By Sydney Lupkin August 23, 2016 KFF Health News Original

Researchers at Harvard University examined thousands of studies to determine why drug prices have climbed and what might be done about it.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Sky-High Prices For Orphan Drugs Slam American Families And Insurers

By Sarah Jane Tribble and Sydney Lupkin Photos by Heidi de Marco January 17, 2017 KFF Health News Original

Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

FDA’s Drug Approval Team Copes With 700 Unfilled Jobs As Industry Lures Staff

By Sydney Lupkin and Sarah Jane Tribble November 3, 2016 KFF Health News Original

The FDA’s drug-approval team is short more than 700 people and losing skilled staff members to the drug industry.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Medicare’s Readmission Penalties Hit New High

By Jordan Rau August 2, 2016 KFF Health News Original

Medicare will withhold an estimated $528 million in 2017 from more than 2,500 hospitals that have too many patients returning within 30 days.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Study Bodes Well For Biosimilars But Highlights Need For More Research

By Sydney Lupkin August 1, 2016 KFF Health News Original

Some experts said the findings stemming from this systematic review of existing studies was reassuring, but not surprising.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
  • Previous
  • 1
  • 2
  • 3
  • 4

More From KFF Health News

A photo of Robert F. Kennedy Jr. at his confirmation hearing in a Senate hearing room.

RFK Jr. Made Promises in Order To Become Health Secretary. He’s Broken Many of Them.

Journalists Unpack Impact of ICE Arrests on Families and Caffeine’s Effect on Dementia Risk

A physician stands in an examination room at a clinic. She has a stethoscope draped over her neck.

Clinics Sour on CMS After Agency Scraps 10-Year Primary Care Program Only Months In

A photo of a White House event: President Trump sits at a table. To the right of him is Robert F. Kennedy Jr. Mehmet Oz sits to Kennedy's right. All three men have microphones across from them.

Trump Team’s Planned ACA Rule Offers Its Answer to Rising Premium Costs: Catastrophic Coverage

KFF

© 2026 KFF. All rights reserved.

  • About Us
  • Donate
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS

Powered by WordPress VIP

Thank you for your interest in supporting KFF Health News, the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!

Continue